Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PTGDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CPA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF20L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UCP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NDUFC2-KCTD14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ATP11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C22orf42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFHX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLCA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRRM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAJIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GCC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZXDB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506585 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUSBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASGEF1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on